ArticleTranslational vision science & technology2022

SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy.

Huy Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.